LYSIS OF ONCORNAVIRUSES BY H U M A N SERUM Isolation of the Viral Complement ( C 1 ) Receptor and Identification as pl 5 E

Human serum inactivates RNA tumor viruses as Welsh and co-workers (1-4) have demonstrated. The mechanism of inactivation was shown to be complement-mediated viral lysis, not requiring virion-specific antibodies. All C-type RNA viruses were lysed by sera from primates but not from rabbits, mice, guinea pigs, or goats. Cooper et al. (4) showed that integrity of the classical complement sequence was an absolute requirement for lysis and that, in absence of specific antibody, Clq I subserved the virus recognition function. The antibody independent nature of this virolytic reaction suggests that complement plays an important role in natural or nonspecific defense against C-type RNA viruses. We have therefore explored the envelope proteins of Moloney leukemia virus as to their capacity to activate complement, and have identified a single, low molecular weight surface protein as the viral receptor and activator of C1.

[1]  R. Bartholomew,et al.  The first complement component: evidence for an equilibrium between C1s free in serum and C1s bound in the C1 complex. , 1977, Journal of immunology.

[2]  R. Arlinghaus,et al.  Common Precursor for Rauscher Leukemia Virus gp69/71, p15(E), and p12(E) , 1977, Journal of virology.

[3]  I. Weissman,et al.  Cellular maturation of oncornavirus glycoproteins: topological arrangement of precursor and product forms in cellular membranes. , 1977, Virology.

[4]  F. Jensen,et al.  Inactivation of lysis of oncornaviruses by human serum. , 1976, Virology.

[5]  F. Jensen,et al.  Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway , 1976, The Journal of experimental medicine.

[6]  H. Müller-Eberhard,et al.  Purification of the sixth and seventh component of human complement without loss of hemolytic activity. , 1976, Journal of immunology.

[7]  J. August,et al.  Structural proteins of ribonucleic acid tumor viruses. Purification of envelope, core, and internal components. , 1976, The Journal of biological chemistry.

[8]  F. Jensen,et al.  Human serum lyses RNA tumour viruses , 1975, Nature.

[9]  F. Jensen,et al.  Lysis of oncornaviruses by human serum. , 1975, Bibliotheca haematologica.

[10]  E. Fleissner,et al.  Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. V. Identification of a new murine viral protein, p15(E) , 1975, Journal of virology.

[11]  G. V. Vande Woude,et al.  A p60 polypeptide in the feline leukemia virus pseudotype of Moloney sarcoma virus with murine leukemia virus p30 antigenic determinants. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Müller-Eberhard,et al.  Neoantigens of the membrane attack complex of human complement. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Arlinghaus,et al.  Biosynthesis of Rauscher leukemia viral proteins , 1975, Cell.

[14]  J. August,et al.  A proposed nomenclature for the virion proteins of oncogenic RNA viruses. , 1974, Virology.

[15]  R. Reisfeld,et al.  Protein iodination with solid state lactoperoxidase. , 1974, Biochemistry.

[16]  H. Müller-Eberhard,et al.  THE MEMBRANE ATTACK MECHANISM OF COMPLEMENT , 1973, The Journal of experimental medicine.

[17]  K. Weber,et al.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.

[18]  T. Pincus,et al.  Characterization of murine leukemia virus-specific proteins. , 1975, Cold Spring Harbor symposia on quantitative biology.

[19]  R. Stroud,et al.  Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies. , 1971, Journal of immunology.